首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS DETERMINATION OF DUTASTERIDE AND TAMSULOSIN IN BULK AS WELL AS IN PHARMACEUTICAL DOSAGE FORM BY USING PDA DETECTOR
【24h】

STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT & VALIDATION FOR SIMULTANEOUS DETERMINATION OF DUTASTERIDE AND TAMSULOSIN IN BULK AS WELL AS IN PHARMACEUTICAL DOSAGE FORM BY USING PDA DETECTOR

机译:PDA检测器同时测定散装中的达多甾酯和牛磺酸以及药物剂量形式的稳定性指示RP-HPLC方法的开发和验证

获取原文
获取外文期刊封面目录资料

摘要

Objective: The present work was undertaken with the aim to develop and validate a rapid and consistent stability indicating RP-HPLC in which the peaks will be appear with short period of time as per ICH Guidelines. The proposed method was simple, fast, accurate and precise method for the Quantification of drug in the dosage form, bulk drug as well as for routine analysis in Quality control. Method: Reversed-phase high-performance liquid chromatography (RP-HPLC) methods was developed and validated for simultaneous estimation of Tamsulosin hydrochloride and Dutasteride in bulk drug and in combined dosage forms. RP-HPLC separation was achieved on a Symmetry C18 (4.6 x 150mm, 5mm, Make: XTerra) under an Isocratic Mode. The mobile phase was composed of Phosphate Buffer (20%) whose pH was adjusted to 2.5 by using Orthophosporic Acid & Acetonitrile (80%) [HPLC Grade]. The flow rate was monitored at 0.8 ml per min. The wavelength was selected for the detection was 274 nm. Result: The run time was 7min. The retention time found for the drugs Dutasteride & Tamsulosin were 2.003 min. & 5.067 min. respectively. The linearity was established in the range of 25 to 125μg/ml. The proposed method was adequate sensitive, reproducible, and specific for the determination of Dutasteride and Tamsulosin hydrochloride in bulk as well as in Pharmaceutical dosage form. The validation of method was carried out utilizing ICH-guidelines. Conclusion: The described RP-HPLC method was successfully employed for the analysis of pharmaceutical formulations containing combined dosage form. The drug was exposed to Thermal, Hydrolytic and Oxidative stress conditions and the stressed samples were analyzed by the proposed method. The peak homogeneity data for the drugs Dutasteride and Tamsulosin hydrochloride were obtained by using Photodiode Array Detector in the stressed sample chromatograms which demonstrated the specificity of the method for the estimation in the presence of degradants. Overall the proposed method was found to be suitable and Accurate for the Quantitative determination and stability study of the drug in Pharmaceutical dosage form. . The method was effectively separated the drug from its degradation product and it was employed as a stability- indicating one. The method was simple, precise, accurate and sensitive and applicable for the simultaneous determination of Dutasteride and Tamsulosin hydrochloride in bulk drug and in combined dosage forms.
机译:目的:开展本工作的目的是开发和验证快速一致的稳定性,表明根据ICH指南,在短时间内出现峰的RP-HPLC。该方法简便,快速,准确,精确,可用于定量剂型,原料药以及质量控制中的常规分析。方法:开发并验证了反相高效液相色谱(RP-HPLC)方法,用于同时估算散装药物和组合剂型中的坦索罗辛盐酸盐和度他雄胺。在等度模式下,在Symmetry C18(4.6 x 150mm,5mm,制造:XTerra)上完成RP-HPLC分离。流动相由磷酸盐缓冲液(20%)组成,通过使用正磷酸和乙腈(80%)[HPLC级]将其pH值调节至2.5。监测流速为每分钟0.8毫升。选择用于检测的波长是274nm。结果:运行时间为7分钟。药物度他雄胺和坦索罗辛的保留时间为2.003分钟。 &5.067分钟。分别。线性建立在25至125μg/ ml的范围内。所提出的方法具有足够的灵敏性,可重现性和特异性,可用于测定散装剂和药物剂型中的度他雄胺和坦索罗辛盐酸盐。方法的验证是利用ICH指南进行的。结论:所描述的RP-HPLC方法已成功地用于分析包含组合剂型的药物制剂。将该药物暴露于热,水解和氧化应激条件下,并通过提出的方法分析了受压样品。药物Dutasteride和Tamsulosin hydrochloride的峰均一性数据是通过使用光电二极管阵列检测器在强调的样品色谱图中获得的,该数据证明了在存在降解物的情况下估算方法的特异性。总体而言,发现所提出的方法适用于药物剂型中药物的定量测定和稳定性研究。 。该方法有效地从降解产物中分离出了药物,并被用作表明稳定性的一种。该方法简便,准确,准确,灵敏,可用于同时测定散装药物和联合剂型中度他雄胺和盐酸坦索罗辛的含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号